Joe Fletcher | executive |
David Ricks | executive |
Lucas Montarce | executive |
Daniel Skovronsky | executive |
Christopher Schott | analyst |
Patrik Jonsson | executive |
Geoffrey Meacham | analyst |
Evan Seigerman | analyst |
Seamus Fernandez | analyst |
Mohit Bansal | analyst |
Ilya Yuffa | executive |
Terence Flynn | analyst |
Umer Raffat | analyst |
Steve Scala | analyst |
David Risinger | analyst |
Kerry Holford | analyst |
Jacob Van Naarden | executive |
Chris Shibutani | analyst |
Trung Huynh | analyst |
Courtney Breen | analyst |
Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q3 2024 Earnings Call. [Operator Instructions] I would now like to turn the conference over to your host, Joe Fletcher, Senior Vice President of Investor Relations. Please go ahead.
Thank you, Paul, and good morning, everybody. Thanks for joining us for Eli Lilly and Company's Q3 2024 Earnings Call.